Glucagon-like peptide-1 receptors (GLP-1Rs ... which coordinates communication to peripheral organs that affect reward signaling. 5 Most research on GLP-1 agonists as a potential therapy for ...
Pattern recognition receptors such as toll-like receptors (TLRs) sense the continuous production of DAMPs and metabolites, thereby triggering downstream signaling pathways ... covers all these aspects ...
In this target trial emulation, glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a lower risk of ...
Background: Glucagon-like peptide-1(7–36)amide (GLP-1) retards gastric emptying, reduces food intake, and inhibits antroduodenal and stimulates pyloric motility. Aims: To assess the effects of ...
Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not associated with short-term postoperative ...
Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 ...
Medical Xpress on MSN11d
Study finds GLP-1 receptor agonists target fat over muscle for weight lossDiabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class ...
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...
News Medical on MSN5d
New study confirms GLP-1 medications are safe for mental health in diabetesResearchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback